|1.||Steward, William P: 2 articles (11/2009 - 06/2005)|
|2.||Gescher, Andreas J: 2 articles (11/2009 - 06/2005)|
|3.||Sale, Stewart: 2 articles (11/2009 - 06/2005)|
|4.||Tosca, Androniki: 1 article (08/2015)|
|5.||Fragiadaki, Irene: 1 article (08/2015)|
|6.||Androutsopoulos, Vasilis Pericles: 1 article (08/2015)|
|7.||Xu, Qi-ping: 1 article (09/2013)|
|8.||Zhang, Lu: 1 article (09/2013)|
|9.||Dai, Fang: 1 article (09/2013)|
|10.||Chen, Liang-ke: 1 article (09/2013)|
02/14/2005 - "Here we report that 3,4,5,4'-tetramethoxystilbene (MR-4), converted from R-4, was more potent against cancer cell lines (WI38VA, IMR-90SV, HeLa, LNCaP, HT-29, and HepG2), but had almost no inhibitory effect on the growth of normal cells (WI38, IMR-90, BJ-T) at the concentrations tested. "
09/01/2013 - "Trans-3,4,5,4'-tetramethoxystilbene (DMU-212) has shown strong antiproliferative activities against a variety of cancer cells. "
12/01/2008 - "Among all of the resveratrol analogs synthesized, 3,4,5,4'-tetramethoxystilbene (DMU-212) shows high activity and selectivity against various cancer cell types. "
12/01/2008 - "Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol."
02/09/2004 - "Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene."
|2.||Colorectal Neoplasms (Colorectal Cancer)
11/01/2009 - "The growth inhibitory properties of 14 putative colorectal cancer chemopreventive agents, tricin, apigenin, 3',4',5',5,7-pentamethoxyflavone, resveratrol, curcumin, 3,4-methylenedioxy-3',4',5'-trimethoxychalcone (DMU135), 3,4,5,4'-tetramethoxystilbene (DMU212), celecoxib, aspirin, piroxicam, all-trans-retinoic acid, difluoromethylornithine (DFMO), quercetin and cyanidin-3-glucoside, were studied in this cell line, and the IC(50) values were calculated. "
|3.||Melanoma (Melanoma, Malignant)
|4.||Colonic Neoplasms (Colon Cancer)
06/10/2005 - "The synthetic resveratrol analog 3,4,5,4'-tetramethoxystilbene (DMU-212) has been shown to possess stronger antiproliferative properties in human colon cancer cells than resveratrol. "
06/10/2005 - "Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells."
|2.||Cyclooxygenase 2 (Cyclooxygenase-2)
|4.||Tretinoin (Retinoic Acid)
|8.||Aspirin (Acetylsalicylic Acid)